Search results
US challenges ‘bogus’ patents on Ozempic and other drugs in effort to spur competition - WTOP News
WTOP Washington· 1 day agoThe Federal Trade Commission on Tuesday sent warning letters to 10 drugmakers, taking issue with patents on popular drugs for weight loss, diabetes, asthma and other reparatory conditions. The ...
US Challenges 'Bogus' Patents on Ozempic and Other Drugs in Effort to Spur Competition
US News & World Report· 1 day agoThe Federal Trade Commission on Tuesday sent warning letters to 10 drugmakers, taking issue with patents on popular drugs for weight loss, diabetes, asthma and other reparatory conditions. The ...
The Ozempic Effect: How a Weight Loss Wonder Drug Gobbled Up an Entire Economy
Bloomberg· 1 day agoThere is no escaping Ozempic and Wegovy. The diabetes and obesity drugs are a global phenomenon. The...
Josh Groban, Andra Day & Rhiannon Giddens Celebrated as 2024 Music Will Honorees
Billboard via Yahoo News· 5 days agoMichael Bearden (Lady Gaga, Whitney Houston) will serve as music director for Music Will’s upcoming...
Earnings call: Ashland Inc. reports mixed Q2 results amid sales dip
Investing.com· 33 minutes agoThe company's adjusted EBITDA fell by 13% to $126 million, although it surpassed expectations....
CRISPR-Crafted Cuisine: How Genetic Engineering Is Changing What We Eat
SciTechDaily· 2 days agoWith animal-free dairy products and convincing vegetarian meat substitutes already on the market,...
US challenges ‘bogus’ patents on Ozempic and other drugs in effort to spur competition
KSAN - KLST San Angelo· 1 day agoWASHINGTON (AP) — Federal regulators are challenging patents on 20 brand-name drugs, including the...
ONWARD® Medical Reports Full Year 2023 Financial and Operating Results and Shares 2024 Highlights...
Morningstar· 7 days ago“In 2023, we made substantial progress against our objectives and laid the foundation to bring our ARC-EX System to the US market later this year,” said Dave Marver, CEO..
US challenges 'bogus' patents on Ozempic and other drugs in effort to spur competition
Associated Press· 1 day agoThe Federal Trade Commission on Tuesday sent warning letters to 10 drugmakers, taking issue with...
Earnings call: Atos reports Q1 2024 performance amid refinancing efforts By Investing.com
Investing.com· 2 days agoDespite the challenges, the company's Tech Foundations segment saw an operating margin improvement....